Francesco Nannini

457 total citations · 1 hit paper
8 papers, 327 citations indexed

About

Francesco Nannini is a scholar working on Oncology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Francesco Nannini has authored 8 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Biomedical Engineering. Recurrent topics in Francesco Nannini's work include CAR-T cell therapy research (5 papers), Nanowire Synthesis and Applications (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Francesco Nannini is often cited by papers focused on CAR-T cell therapy research (5 papers), Nanowire Synthesis and Applications (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Francesco Nannini collaborates with scholars based in United Kingdom, India and Austria. Francesco Nannini's co-authors include Martin Pulé, Sergio A. Quezada, Nicolás Gonzalo Núñez, Mark F. Lythgoe, Burkhard Becher, Alastair Hotblack, Bernard Siow, Anna Rita Liuzzi, Cassandra Stowe and Thomas A. Roberts and has published in prestigious journals such as Nature Communications, Blood and Scientific Reports.

In The Last Decade

Francesco Nannini

8 papers receiving 322 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma

2021 222 citations Giulia Agliardi, Anna Rita Liuzzi et al. Nature Communications profile →

Peers

Countries citing papers authored by Francesco Nannini

Since Specialization

Citations

This map shows the geographic impact of Francesco Nannini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Nannini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Nannini more than expected).

Fields of papers citing papers by Francesco Nannini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Nannini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Nannini. The network helps show where Francesco Nannini may publish in the future.

Co-authorship network of co-authors of Francesco Nannini

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Nannini. A scholar is included among the top collaborators of Francesco Nannini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Nannini. Francesco Nannini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Inhibition of lactate transport by MCT-1 blockade improves chimeric antigen receptor T-cell therapy against B-cell malignancies 2023 ·Journal for ImmunoTherapy of Cancer ·Ernesto López, (unknown), Francesco Nannini, Gordon Weng-Kit Cheung, (unknown), Felipe Gálvez‐Cancino, Sergio A. Quezada, Martin Pulé	33
2	Enhancing CAR T-cell Therapy Using Fab-Based Constitutively Heterodimeric Cytokine Receptors 2023 ·Cancer Immunology Research ·(unknown), (unknown), Mathew Robson, (unknown), Evangelia Kokalaki, (unknown), Francesco Nannini, Christopher Allen, (unknown), James Sillibourne, Shaun Cordoba, Simon Thomas, Martin Pulé	6
3	IMMU-16. Next-generation CAR T-cells targeting IL13RA2 and secreting IL-15 achieve durable tumour clearance in pre-clinical model of diffuse midline glioma 2022 ·Neuro-Oncology ·Alastair Hotblack, Patrycja Wawrzyniecka, (unknown), Francesco Nannini, Martin Pulé, Karin Straathof	1
4	Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma breakdown → 2021 ·Nature Communications ·Giulia Agliardi, Anna Rita Liuzzi, Alastair Hotblack, Donatella De Feo, Nicolás Gonzalo Núñez, Cassandra Stowe, Ekaterina Friebel, Francesco Nannini, Lukas Rindlisbacher, Thomas A. Roberts, Rajiv Ramasawmy, (unknown), Bernard Siow, Mark F. Lythgoe, Tammy L. Kalber, Sergio A. Quezada, Martin Pulé, Sònia Tugues, Karin Straathof, Burkhard Becher	222
5	Anti-CD21 Chimeric Antigen Receptor (CAR)-T Cells for T Cell Acute Lymphoblastic Leukaemia (T-ALL) 2021 ·Blood ·(unknown), (unknown), Francesco Nannini, Patrycja Wawrzyniecka, (unknown), (unknown), Mathieu Ferrari, Teresa Marafioti, Shimobi Onuoha, Asim Khwaja, Paul Maciocia, Martin Pulé	7
6	A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats 2020 ·Scientific Reports ·Francesco Nannini, (unknown), Patrycja Wawrzyniecka, Leila Mekkaoui, (unknown), (unknown), Jenny Yeung, Claire Roddie, (unknown), Biao Ma, Mathieu Ferrari, Shimobi Onuoha, Kerry Chester, Martin Pulé	4
7	Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments 2020 ·mAbs ·Francesco Nannini, (unknown), (unknown), (unknown), (unknown), Reyisa Bughda, James Sillibourne, Xihao Hu, Biao Ma, (unknown), Mathieu Ferrari, Martin Pulé, Shimobi Onuoha	16
8	Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis 2015 ·Journal of Clinical Microbiology ·Gemma Johnson, Shah‐Jalal Sarker, Francesco Nannini, Arianna Ferrini, Emma Taylor, Cornelia Lass‐Flörl, (unknown), Stephen A. Bustin, Samir Agrawal	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact